-
Study aim
-
Determining the relationship between astaxanthin consumption and plasma inflammatory factors Hs-CRP, IL-18, TNFα, -IL-6, IL-1b, NF-κB and, expression of genes related to endoplasmic reticulum pathway and apoptosis in Pbmc
-
Design
-
This Triple-blind randomized clinical trial, controlled by placebo, based on the guidelines contained in the Helsinki Declaration, after obtaining permission from the ethics committee of Tehran University of Medical Sciences, 501 patients will be recruited. Prior to the intervention, written informed consent will be obtained from all participants
-
Settings and conduct
-
The location of the experiment:Tehran University of Medical Sciences. Sampling location: Omid fertility center. Isolation of blood serum and measurement of inflammatory factors - Isolation of pripheral blood mononuclear cells (Pbmc)- Assessment of the expression of ER stress and apoptotic pathway genes in pbmc;
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: patients with PCOS-induced infertility at the age of 18-40 years. Exclusion criteria: pregnancy; adrenal hyperplasia; androgen-secreting tumors; hyperprolactinemia; thyroid dysfunction; diabetes or glucose tolerance disorder and male infertility factors.
-
Intervention groups
-
Astaxanthin consumer. Placebo consumer.
-
Main outcome variables
-
Plasma inflammatory factors include Hs-CRP, IL-18, IL-6, TNF-α, IL-1β and NF-κB;
Endoplasmic reticulum stress pathway and apoptosis genes in Pbmc:
ATF4, ATF6, XBP1, GRP78, CHOP, DR5, BCL2, BAX.Caspase8